April 5, 2024
You are here:  Home  >  Banking & Finance  >  Current Article

Amgen reports revenue spike from COVID treatment collaboration


Amgen saw its revenue and net income rise in the fourth quarter of 2021, as COVID-19 treatments made in collaboration with Eli Lilly and Company helped bolster the Thousand Oaks-based biotech company’s finances, Amgen reported Feb. 7. In the fourth quarter of 2021, Amgen generated revenue of $6.8 billion, a 3% increase from the same…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.